Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery

被引:328
作者
Desai, Pinaki [1 ]
Patlolla, Ram R. [2 ]
Singh, Mandip [1 ]
机构
[1] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA
[2] Dr Reddys Labs, Integrated Prod Dev, Hyderabad, Andhra Pradesh, India
基金
美国国家卫生研究院;
关键词
Topical and transdermal skin delivery; nanoparticles; cell-penetrating peptides; PROTEIN-TRANSDUCTION-DOMAINS; SOLID LIPID NANOPARTICLES; QUANTUM-DOT NANOPARTICLES; ARGININE-RICH PEPTIDES; HAIR-FOLLICLES; IN-VITRO; MAMMALIAN-CELLS; PHYSICOCHEMICAL PROPERTIES; INTRACELLULAR DELIVERY; ENHANCED TRANSDUCTION;
D O I
10.3109/09687688.2010.522203
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Topical or transdermal drug delivery is challenging because the skin acts as a natural and protective barrier. Therefore, several methods have been examined to increase the permeation of therapeutic molecules into and through the skin. One approach is to use the nanoparticulate delivery system. Starting with liposomes and other vesicular systems, several other types of nanosized drug carriers have been developed such as solid lipid nanoparticles, nanostructured lipid carriers, polymer-based nanoparticles and magnetic nanoparticles for dermatological applications. This review article discusses how different particulate systems can interact and penetrate into the skin barrier. In this review, the effectiveness of nanoparticles, as well as possible mode of actions of nanoparticles, is presented. In addition to nanoparticles, cell-penetrating peptide (CPP)-mediated drug delivery into the skin and the possible mechanism of CPP-derived delivery into the skin is discussed. Lastly, the effectiveness and possible mechanism of CPP-modified nanocarriers into the skin are addressed.
引用
收藏
页码:247 / 259
页数:13
相关论文
共 86 条
[81]   40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin [J].
Vogt, Annika ;
Combadiere, Behazine ;
Hadam, Sabrina ;
Stieler, Karola M. ;
Lademann, Juergen ;
Schaefer, Hans ;
Autran, Brigitte ;
Sterry, Wolfram ;
Blume-Peytavi, Ulrike .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (06) :1316-1322
[82]   Biophysical and biological studies of end-group-modified derivatives of Pep-1 [J].
Weller, K ;
Lauber, S ;
Lerch, M ;
Renaud, A ;
Merkle, HP ;
Zerbe, O .
BIOCHEMISTRY, 2005, 44 (48) :15799-15811
[83]   Oligocarbamate molecular transporters: Design, synthesis, and biological evaluation of a new class of transporters for drug delivery [J].
Wender, PA ;
Rothbard, JB ;
Jessop, TC ;
Kreider, EL ;
Wylie, BL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (45) :13382-13383
[84]   Cosmetic applications for solid lipid nanoparticles (SLN) [J].
Wissing, SA ;
Müller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 254 (01) :65-68
[85]   Assessment of quantum dot penetration into intact, tape-stripped, abraded and flexed rat skin [J].
Zhang, L. W. ;
Monteiro-Riviere, N. A. .
SKIN PHARMACOLOGY AND PHYSIOLOGY, 2008, 21 (03) :166-180
[86]   Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes [J].
Zhang, Leshuai W. ;
Yu, William W. ;
Colvin, Vicki L. ;
Monteiro-Riviere, Nancy A. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2008, 228 (02) :200-211